Synthesize Bio
PrivateLast Round
Seed
Sep 17, 2025
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synthesize Bio is a biotechnology company that develops a generative genomics platform using multi-modal deep learning models to simulate biological processes and accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthesize Bio Comparables
Compare Synthesize Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 89% | |
| Chai Discovery | 83% | |
| Cassidy Bio | 81% |
Synthesize Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2025 |
Key People
Founding team and executive leadership
Synthesize Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AI2 Incubator | Seed |
| Madrona Venture Group | Seed |
| Point Field Partners | Seed |
| Sahsen Ventures | Seed |
| Inner Loop Capital | Seed |
| AI House | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 24% QoQ from 17 to 21 employees.
Synthesize Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synthesize Bio's valuation, stock price, and market status.
Is Synthesize Bio a public or private company?
Synthesize Bio is a private company.
What is the current stock price of Synthesize Bio?
Synthesize Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Synthesize Bio worth (valuation)?
Valuation information for Synthesize Bio is not publicly available.
Can I buy Synthesize Bio stock?
Synthesize Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synthesize Bio's last funding round?
Synthesize Bio's most recent funding round was Seed on September 17, 2025.
Who are the main investors in Synthesize Bio?
Key investors in Synthesize Bio include Madrona Venture Group.
Will Synthesize Bio IPO soon?
No public IPO plans have been announced for Synthesize Bio.
How can I track Synthesize Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synthesize Bio's secondary market activity and sign up for updates.